Nuriss Skincare And Wellness Limited Secures £605k in Latest Funding Round

Nuriss Skincare And Wellness Limited, a London-based company operating doctor-led skin and wellbeing clinics, has successfully raised £605k in its latest funding round. The round, which saw an estimated post-money valuation of £9.6m, was filed on 2026-04-30, with the allotment date recorded as 2026-04-29.

Founded on 2014-03-25, Nuriss Skincare And Wellness Limited distinguishes itself by offering medical-grade procedures including laser, radiofrequency, ultrasound, and injectable treatments for various skin conditions, anti-aging, and hair restoration. The company also provides its own exclusive skincare range and personalised treatment plans that address both external skin health and internal wellbeing. This approach is rooted in the philosophy that healthy skin and body require attention to internal wellbeing alongside external skin health. The company's multidisciplinary team aims to deliver personalised treatment programmes that integrate wellbeing strategies to balance gut health and hormones for optimal results.

According to its latest accounts, Nuriss Skincare And Wellness Limited employs 12 individuals. Its LinkedIn profile indicates 8 employees and lists its industry as Medical Practices, with its headquarters in London.

This recent £605k funding injection follows a series of previous capital raises for Nuriss. The company has a history of securing investment, with notable rounds including £15.9k on 2024-11-04, £232.5k on 2024-10-31, and £76.6k on 2024-10-01. Further back, it raised £249.7k on 2023-10-04, £797.1k on 2022-03-02, and £407.1k on 2022-03-01. Earlier rounds include £188.6k on 2021-09-17, £257.1k on 2021-05-25 at a valuation of £10.8m, £1.2m on 2019-08-15, and £316.2k on 2019-05-03. The current post-money valuation of £9.6m represents a decrease compared to its £10.8m valuation recorded during the 2021-05-25 funding round.

In terms of recent corporate activity, Amit Karia was appointed as a director on 2026-04-06.

The funding landscape for health and wellness companies in the UK has shown resilience and growth. The broader UK healthcare sector experienced a 36.06% rise in funding in 2025 compared to the previous year, with companies raising $222M across 40 rounds by December 2025. More specifically, the UK HealthTech and life sciences sectors saw significant venture capital investment, with Q1 2025 recording £1.4 billion, an 8% increase over Q1 2024, making health the most funded sector in the UK by a considerable margin. The European digital health funding landscape also demonstrated robust growth, with a 52% year-on-year increase in the first half of 2025, reaching $3.4 Billion across 182 deals, with the UK's HealthTech sector being a key contributor to this regional strength. The UK MedTech market alone is projected to reach £15.7 Billion in 2025, with forecasts indicating steady growth to £20.5 Billion by 2030. While overall biotech funding in Q1 2026, at £552 million, was below the £924 million of Q1 2025, the recent period has been characterised by a broader distribution of capital across more companies and stages, with deal activity increasing significantly by 67% year-on-year to 25 VC transactions. The UK notably secured 57% of all European biotech venture capital in Q1 2026, highlighting its continued strength in the sector. This context suggests a dynamic, albeit sometimes fluctuating, environment for health and wellness businesses like Nuriss Skincare And Wellness Limited in the UK.